MDL | MFCD00056008 |
---|---|
Molecular Weight | 339.41 |
Molecular Formula | C14H21N5O3S |
SMILES | O[C@@H]([C@H]([C@H](N1C=NC2=C1N=CN=C2N)O3)O)[C@H]3CSCC(C)C |
SIBA (5'-Isobutylthioadenosine) is a transmethylation inhibitor ( SAH (HY-19528) analogue), with potent anti-proliferative activity. SIBA reversibly inhibits the production of HSV-1 by blocking methylation, specifically by blocking the 5' end-capping of viral mRNA. SIBA also inhibits the growth of tumour cells in vitro and metastatic spread in vivo. SIBA can be used in cancer , HSV-1 infection and anti-malaria studies [1] [2] [3] .
Plasmodium |
HSV-1 |
SIBA (0.5 mM; 24-96 h) shows strong anti-proliferative activity against 3LL and RMS-J1 tumour cells
[1]
.
SIBA (1 mM; 12, 24 h) reversibly inhibits HSV production in HEp2 cells (infected by HSV-1)
[2]
.
SIBA inhibits protein synthesis by 98% after 10 h infection of HEp2 cells (infected by HSV-1)
[2]
.
SIBA (1 mM; 8.5 h) inhibits protein synthesis and RNA methylation in HEp2 cells (infected by HSV-1)
[2]
.
SIBA (0.5, 1.0 mM; 24, 48 h) inhibits the conversion of putrescine into spermidine and/or spermine and that this inhibition is a reversible one (interferes with polyamine biosynthesis, probably by blocking aminopropyltransferase)
[3]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Cell Proliferation Assay [1]
Cell Line: | 3 LL and RMS-J1 cells |
Concentration: | 0.5 mM |
Incubation Time: | 24-96 h |
Result: | Inhibited 3LL and RMS-J1 tumor cell growth potently by 96% and 88%, respectively. |
Cell Viability Assay [2]
Cell Line: | HEp2 cells (infected by HSV-1) |
Concentration: | 1 mM |
Incubation Time: | 12, 24 h |
Result: | Decreased virus production by 88.4 and 98.2% when at 12 and 24 h, respectively. |
Cell Viability Assay [2]
Cell Line: | HEp2 cells (infected by HSV-1) |
Concentration: | 1 mM |
Incubation Time: | 8.5 h |
Result: |
Reduced protein synthesis by 41.3% in normal medium and by 63.5% in medium poor in methionine.
Inhibited RNA methylation by 65.4%. |
Cell Viability Assay [3]
Cell Line: | chick embryo fibroblasts |
Concentration: | 0.5, 1.0 mM |
Incubation Time: | 24, 48 h |
Result: |
Inhibited the uptake of the radioactive diamine and that the inhibition was dose-dependent.
Markedly inhibited the formation of [ 14 C]spermidine and [ 14 C]spermine from [ 14 C]putrescine. Inhibited the growth of chick embryo fibroblasts mainly after exposure for 48 h. |
SIBA (150 mg/kg; i.p.; twice weekly for 3 weeks) inhibits tumor growth in vivo
[1]
.
SIBA (15 mg/kg; i.p.; thrice weekly for 4 weeks) inhibits metastatic spread of RMS-J1 cells in vivo
[1]
.
MCE has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: | C57BL/6 female mice (4-8 weeks old) [1] . |
Dosage: | 150 mg/kg |
Administration: | Intraperitoneal injection; twice weekly for 3 weeks. |
Result: | Significantly reduced the median number of lung metastases. |
Animal Model: | Adult syngeneic Wistar AG rats (8-week-old; subcutaneously grafted with RMS-J1 cells) [1] . |
Dosage: | 15 mg/kg |
Administration: | Intraperitoneal injection; thrice weekly for 4 weeks. |
Result: | Inhibited in vivo metastatic spread of RMS-J1 cells, and showed median numbers of lung metastatic nodules was 26. |
Solid
Room temperature in continental US; may vary elsewhere.
Powder | -20°C | 3 years |
---|---|---|
4°C | 2 years | |
In solvent | -80°C | 6 months |
-20°C | 1 month |
DMSO : ≥ 100 mg/mL ( 294.63 mM )
* "≥" means soluble, but saturation unknown.
Concentration Solvent Mass | 1 mg | 5 mg | 10 mg |
---|
1 mM | 2.9463 mL | 14.7314 mL | 29.4629 mL |
5 mM | 0.5893 mL | 2.9463 mL | 5.8926 mL |
10 mM | 0.2946 mL | 1.4731 mL | 2.9463 mL |